Rakuten Securities’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.77K Buy
35
+27
+338% +$2.29K ﹤0.01% 619
2026
Q1
$689 Sell
8
-130
-94% -$11.7K ﹤0.01% 713
2025
Q4
$12K Buy
+138
New +$10.5K ﹤0.01% 412
2025
Q3
Sell
-1
Closed -$59 924
2025
Q2
$59 Hold
1
﹤0.01% 820
2025
Q1
$73 Buy
+1
New +$83 ﹤0.01% 801
2024
Q3
Sell
-300
Closed -$20.5K 749
2024
Q2
$20.5K Sell
300
-738
-71% -$44.1K 0.01% 255
2024
Q1
$55.7K Buy
+1,038
New +$55.8K 0.02% 176

Other funds holding GMED

Rakuten Securities's GMED Position: Q2 2026 in Review

Rakuten Securities increased its Globus Medical (GMED) stake by 338% in Q2 2026, buying an estimated $2.29K and bringing the position to 35 shares worth $2.77K. The position accounts for ﹤0.01% of the portfolio, ranked #619.

Rakuten Securities first reported a position in GMED in Q1 2024 and has held it in 7 quarters since. The position peaked at $55.7K in Q1 2024. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Rakuten Securities held 35 shares of Globus Medical worth $2.77K as of Q2 2026.
  • Rakuten Securities bought 27 Globus Medical shares in Q2 2026, an estimated $2.29K.
  • Globus Medical made up ﹤0.01% of Rakuten Securities's portfolio in Q2 2026, its #619 holding.
  • Rakuten Securities first reported a position in Globus Medical in Q1 2024 and has held it in 7 quarters since.
  • Rakuten Securities's Globus Medical position peaked at $55.7K in Q1 2024.
  • 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.